Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital. 1975

R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson

Cocaine, methylphenidate and secobarbital were compared on a drug maintained progressive-ratio procedure in baboon subjects. Trials, scheduled throughout the day, occurred at a minimum interval of 3 hrs after completion of the preceding trial. A ratio response requirement on the "initiate" lever was required during each trial which terminated in a single intravenous infusion of drug. A drug was introduced on the progressive-ratio procedure with a low ratio requirement in order to obtain a baseline performance of a high stable frequency of trial completion. The ratio requirement was systematically increased every 7 days until the "breaking point" when the rate of completing trials fell below a criterion level. Within-subject comparison revealed that cocaine produced higher breaking points than methylphenidate at the same absolute dose, 0.4 mg/kg. At the range of doses studied, manipulation of doses of methylphenidate (0.1-0.8 mg/kg) and cocaine (0.4-1.6 mg/kg) had little effect on breaking point. In contrast, increasing doses of secobarbital (6.0 and 12.0 mg/kg) produce higher breaking points within the same subjects.

UI MeSH Term Description Entries
D008297 Male Males
D008774 Methylphenidate A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE. Centedrin,Concerta,Daytrana,Equasym,Metadate,Methylin,Methylphenidate Hydrochloride,Phenidylate,Ritalin,Ritalin-SR,Ritaline,Tsentedrin,Hydrochloride, Methylphenidate,Ritalin SR
D012055 Reinforcement Schedule A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. Reinforcement Schedules,Schedule, Reinforcement,Schedules, Reinforcement
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D012631 Secobarbital A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity. Meballymal,Quinalbarbitone,Sebar,Secobarbital Sodium,Seconal,Seconal Sodium,Sodium, Secobarbital

Related Publications

R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
January 1978, Psychopharmacology,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
October 1979, Psychopharmacology,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
January 2009, Journal of the experimental analysis of behavior,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
April 1979, Psychopharmacology,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
May 1988, Drug and alcohol dependence,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
December 1977, Pharmacology, biochemistry, and behavior,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
November 1978, Pharmacology, biochemistry, and behavior,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
June 2003, Psychopharmacology,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
December 1999, Behavioural pharmacology,
R R Griffiths, and J D Findley, and J V Brady, and K Dolan-Gutcher, and W W Robinson
February 2003, Behavioural pharmacology,
Copied contents to your clipboard!